Information on the total number of voting rights and shares
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
Nyxoah SA (NYXH) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Nyxoah SA (NYXH) Q1 2026 Earnings Call Transcript
Nyxoah Q1 Earnings Call Highlights
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
Nyxoah Reports First Quarter 2026 Financial and Operating Results
Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026
Nyxoah Reports First Quarter 2026 Financial and Operating Results
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
Financial Analysis: Omnicell (NASDAQ:OMCL) versus Nyxoah (NASDAQ:NYXH)
Analyzing Rennova Health (OTCMKTS:RNVA) & Nyxoah (NASDAQ:NYXH)
Publication relating to transparency notifications
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Publication relating to transparency notification
Publication relative à une notification de transparence
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Brokerages Set Nyxoah SA (NASDAQ:NYXH) PT at $11.67
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Information on the total number of voting rights and shares
Comparing Healthcare Triangle (NASDAQ:HCTI) and Nyxoah (NASDAQ:NYXH)
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
Nyxoah SA (NASDAQ:NYXH) Short Interest Up 29.0% in January
Contrasting Hinge Health (NYSE:HNGE) and Nyxoah (NASDAQ:NYXH)
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Publication relating to transparency notification
Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH)
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
Publication relating to transparency notifications
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Information on the total number of voting rights and shares
Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025
Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System